相似文献
1
Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
J Exp Med. 1976 May 1;143(5):1283-8. doi: 10.1084/jem.143.5.1283.
2
Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
J Immunol. 1976 Dec;117(6):2233-8.
3
H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
Eur J Immunol. 1976 Mar;6(3):150-6. doi: 10.1002/eji.1830060303.
4
Cytotoxic T cell response to minor histocompatibility antigens: apparent lack of H-2 restriction in killers stimulated by membrane fragments.
J Exp Med. 1982 Jul 1;156(1):217-29. doi: 10.1084/jem.156.1.217.
5
Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y.
J Immunol. 1981 Aug;127(2):686-9.
6
Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
Cell Immunol. 1985 Mar;91(1):100-10. doi: 10.1016/0008-8749(85)90035-8.
7
H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
J Exp Med. 1979 Jun 1;149(6):1407-23. doi: 10.1084/jem.149.6.1407.
8
Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
J Natl Cancer Inst. 1983 Feb;70(2):291-7.
9
10
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.
J Exp Med. 1975 Dec 1;142(6):1349-64. doi: 10.1084/jem.142.6.1349.
引用本文的文献
1
Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses.
Vet Sci. 2025 Jul 24;12(8):692. doi: 10.3390/vetsci12080692.
2
Balancing Immunity: GSK-3's Divergent Roles in Dendritic Cell-Mediated T-Cell Priming and Memory Responses.
Int J Mol Sci. 2025 Jun 25;26(13):6078. doi: 10.3390/ijms26136078.
3
Cross-priming in cancer immunology and immunotherapy.
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
4
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.
Clin Exp Med. 2024 Dec 25;25(1):24. doi: 10.1007/s10238-024-01541-7.
5
Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections.
Vaccines (Basel). 2024 Aug 28;12(9):981. doi: 10.3390/vaccines12090981.
6
Dendritic Cells in Shaping Anti-Tumor T Cell Response.
Cancers (Basel). 2024 Jun 13;16(12):2211. doi: 10.3390/cancers16122211.
7
Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders.
J Mol Biol. 2024 Feb 15;436(4):168446. doi: 10.1016/j.jmb.2024.168446. Epub 2024 Jan 17.
8
The transcription factor Zeb1 controls homeostasis and function of type 1 conventional dendritic cells.
Nat Commun. 2023 Oct 20;14(1):6639. doi: 10.1038/s41467-023-42428-7.
9
The role of CD4 T cells in tumor and chronic viral immune responses.
MedComm (2020). 2023 Oct 10;4(5):e390. doi: 10.1002/mco2.390. eCollection 2023 Oct.
10
Transcriptional regulation of dendritic cell development and function.
Front Immunol. 2023 Jul 14;14:1182553. doi: 10.3389/fimmu.2023.1182553. eCollection 2023.
本文引用的文献
1
Absence of gene interaction in mouse hybrids, revealed by studies of immunological tolerance and homotransplantation.
Proc Soc Exp Biol Med. 1959 Aug-Sep;101:658-60. doi: 10.3181/00379727-101-25051.
2
A new method of typing inbred strains of mice for histocompatibility antigens.
Transplant Bull. 1957 Jan;4(1):18-21.
3
Genetics and immunology of sex-linked antigens.
Adv Immunol. 1972;15:215-47. doi: 10.1016/s0065-2776(08)60686-0.
4
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
Eur J Immunol. 1975 Apr;5(4):245-51. doi: 10.1002/eji.1830050405.
5
In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.
J Exp Med. 1975 Nov 1;142(5):1108-20. doi: 10.1084/jem.142.5.1108.
6
Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier.
Nature. 1975 Jul 31;256(5516):419-21. doi: 10.1038/256419a0.
7
The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products.
Transplant Rev. 1975;22:175-95. doi: 10.1111/j.1600-065x.1975.tb01559.x.
8
Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex.
Nature. 1975 Mar 20;254(5497):269-70. doi: 10.1038/254269a0.
9
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.
J Exp Med. 1975 Dec 1;142(6):1349-64. doi: 10.1084/jem.142.6.1349.
10
H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;
J Exp Med. 1975 Jun 1;141(6):1427-36. doi: 10.1084/jem.141.6.1427.
Zotero 插件